IGF1 and cancer: The inhibition of this complex network seems to be a requirement to develop anti-tumor strategies and we corroborate the hypothesis that miRNAs could improve the hormonal and metabolic pattern associated with BC risk, such as IGF-I, in response to the dietary intervention, slowing or inhibiting cancer growth in BRCA mutation carriers.